Understanding genetic differences in long-diverged mouse species
Genetic dissection of trait variation between long-diverged mouse species
This study is looking at how different mouse species have developed special traits over time, and by understanding the genes behind these traits, it hopes to help create new medicines that could improve disease resistance in people.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of California Berkeley NIH-funded |
| Lab location | 1 site (Berkeley, United States) |
| Project ID | NIH-10674502 on NIH RePORTER |
What this research studies
This research investigates the genetic basis of unique traits found in different mouse species that have evolved separately over millions of years. By using a novel approach involving sterile interspecific hybrids, the researchers aim to identify the genes responsible for specific phenotypes, which could provide insights into disease resistance and other important biological characteristics. The study seeks to bridge the gap in genetic mapping techniques that are typically ineffective for species that cannot interbreed. Patients may benefit from the findings as they could lead to the development of new drugs that mimic natural resistance traits observed in these mice.
Who could benefit from this research
Good fit: Ideal candidates for participation or benefit from this research would include individuals with genetic conditions that could be addressed through novel therapeutic approaches.
Not a fit: Patients with conditions unrelated to genetic traits or those not amenable to drug design may not receive any benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new drug designs that enhance disease resistance in humans.
How similar studies have performed: Other research has shown success in using genetic mapping techniques to identify traits in model organisms, suggesting that this approach may yield valuable insights.
Where this research is happening
Berkeley, United States
- University of California Berkeley — Berkeley, United States (Active)
Researchers
- Principal investigator: Brem, Rachel Beth — University of California Berkeley
- Study coordinator: Brem, Rachel Beth
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.